Decision points
Three lanes that must not blur together
The same ingredient name can appear in very different products. The lane tells you what has been reviewed, what can be checked and what question comes next.
An approved medicine
Records from the Food and Drug Administration, or FDA, current in September 2026 show approved medicines containing semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro and Zepbound).
The approved use depends on the brand and form. Ask which condition the prescriber is treating.
- Exact ingredient and brand
- Exact form
- Reason for use
- Current FDA label
A medicine made to order
A compounded medicine is made by a pharmacy or physician for a patient need. It can be lawful, but the FDA neither approves it nor reviews it before it reaches the market.
Ask why the approved medicine does not meet the need and which pharmacy will make the compounded version.
- Name the patient need.
- Name the pharmacy or doctor that made it.
- Check the state licence.
- Ask who handles a problem after delivery.
A research-only product
An online seller’s “for research use only” label did not make a chemical a lawful treatment option as of September 2026. FDA warning letters say the sales claims can show that such a product is really being sold for human use.
If a page sells a small bottle marked “research only” beside mixing water, a dosing guide or a calculator meant to work out an amount, the label and the treatment pitch do not match.
Next in the pathway
Turn the lane into direct questions
A short script keeps the conversation clear.